Based on the maximum likelihood ratio of 532.70 ng/mL as the critical value, the level of Alu-based CFD presented 78.96% sensitivity and 91.81% specificity in separating GC patients, which are significantly higher than serum CEA, CA19-9, CA72-4 and CA50. This evidence concerns the gene CEACAM5 and gastric cancer.